AzTrials
AzTrials

Public HealthNCT04377581

COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior

An observational study of Public Health and Demography, run by Milton S. Hershey Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Effective communication is a critical component of managing pandemic outbreaks like COVID-19. This study explores COVID-19 related public knowledge, perceptions, belief in public health recommendations, intent to comply with public health recommendations, trust in information sources and preferred information sources. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Public Health, Demography, Pandemics
How many people
18,251 participants
Where
1 siteUnited States
Study dates
9 Apr 2020to 10 Jul 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Human Adults

Who may be able to join

  • 18 years of age

Who cannot join

  • Below 18 years of age

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Penn State College of Medicine

    Hershey, Pennsylvania, 17033

Other trials in United States

About this study

Effective communication is a critical component of managing pandemic outbreaks like COVID-19. This study explores COVID-19 related public knowledge, perceptions, belief in public health recommendations, intent to comply with public health recommendations, trust in information sources and preferred information sources. Participants are invited to include detailed free-text answers to make sure their COVID-19 experiences are heard.

Read the detailed description

The survey is available online in 23 languages. Free-text responses in native languages are highly encouraged. A robust global response will not only provide invaluable information to inform clinicians, healthcare institutions and governments about how to optimize the content and venue of COVID-19 messaging, but will help write a Story of COVID in the words and languages of people from all over the world.

Keywords
Penn State, CHIME, COVID-19 Messaging Study
Medical subject headings
Coronavirus Infections

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knowledge and Confidence in Knowledge of COVID-19

    Binary knowledge measures (true/false questions pertaining to COVID-19) each have a corresponding 5-point confidence score, the inverse of which generates a weighting variable. Weighted knowledge scores will be analyzed via a generalized linear mixed-methods effects model with a logistic link function and a random effect for the participant, generating a probability of correct response from 0 to 1.0.

    Measured: Through study completion, an average of 3 months.

  2. Beliefs about the effectiveness of public health recommendations

    Participants are asked, "Do you think that following these CDC recommendations will decrease the spread of COVID-19 in your community?" and select from a 5-point scale, Minimum: 1=certainly not; Maximum: 5 = most certainly.

    Measured: Through study completion, an average of 3 months.

  3. Intent to comply with public health recommendations

    Participants are asked, "Will you follow these recommendations?" and select from a 5-point scale, Minimum: 1=certainly not; Maximum: 5 = most certainly.

    Measured: Through study completion, an average of 3 months.

  4. Perception of Risk of COVID-19 and other health threats

    Participants are asked, "How likely is it that you will be diagnosed with any of the following diseases over the next year?" and rate their perceived likelihood of diagnosis for Measles, Flu, Lung Cancer, Ebola and COVID-19 on a 5 point scale. Minimum: 1, very unlikely; Maximum: 5, very likely.

    Participants are asked, "How serious do you think infection with any of the following diseases would be (or is) to your own personal health?" and rate their perceived seriousness of diagnosis for Measles, Flu, Lung Cancer, Ebola and COVID-19 on a 5 point scale. Minimum: 1, Not at all Serious; Maximum: 5, Very Serious

    Measured: Through study completion, an average of 3 months.

  5. Perceptions of trust in common health information sources

    Participants are asked the extent to which they trust common information sources: The World Health Organization, The U.S. Centers for Disease Control and Prevention, the European Commission, the participant's national government, the participant's local government, and the participant's personal healthcare provider. Participants rate on a 5 point scale. Minimum: 1, Not at all; Maximum: 2, Completely. (As these sources are not recognized in all places, participants may select "Not Applicable" in lieu of ranking.

    Measured: Through study completion, an average of 3 months.

  6. Single most trusted news source

    Participants are asked to identify their single most trusted source of news through selection from a pre-generated list or via free-text.

    Measured: Through study completion, an average of 3 months.

Secondary outcomes (4)
  1. Intention to change consumption of news because of COVID-19 (yes/no)

    Participants are asked if COVID-19 will change how they consume news (y/n)

    Measured: Through study completion, an average of 3 months.

  2. For participants who will change their news consumption, in what way will they change?

    Participants who answer, "Yes" to Outcome 7 are asked to provide a free-text response to describe how their consumption of news will change.

    Measured: Through study completion, an average of 3 months.

  3. Secondary information sources

    Participants are asked to identify all other sources of information via selection from pre-generated menu or free-text.

    Measured: Through study completion, an average of 3 months.

  4. Concerns about COVID-19

    Free-text response invited to describe their concerns regarding COVID-19.

    Measured: Through study completion, an average of 3 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2020
  2. Study start9 Apr 2020
  3. Primary completion10 Jul 2020
  4. Study completion10 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrolment
18,251 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04377581
Sponsor's protocol ID
STUDY00014798
Status last verified
Jul 2020
First submitted
30 Apr 2020
Last updated
16 Jul 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Public Health and Demography, run by Milton S. Hershey Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knowledge and Confidence in Knowledge of COVID-19 (time frame: Through study completion, an average of 3 months.). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2020; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in